Actual practice of standard treatment for pulmonary nontuberculous mycobacteriosis in Japan
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 158, 67-69
Abstract
No abstract availableKeywords
Funding Information
- Biodiversity Institute of Ontario (JP18fk0108043)
- Japan Agency for Medical Research and Development (JP18fk0108043)
This publication has 13 references indexed in Scilit:
- A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013Annals of the American Thoracic Society, 2017
- Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseasesEuropean Respiratory Journal, 2016
- Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung DiseaseAntimicrobial Agents and Chemotherapy, 2016
- Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive CasesAnnals of the American Thoracic Society, 2016
- Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung diseaseBMC Infectious Diseases, 2015
- Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung DiseaseChest, 2014
- Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung DiseaseAnnals of the American Thoracic Society, 2014
- A Steady Increase in Nontuberculous Mycobacteriosis Mortality and Estimated Prevalence in JapanAnnals of the American Thoracic Society, 2014
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2006